Wellington Management Group Portfolio holdings
Wellington Management Group, founded in 1928 by Walter L. Morgan and headquartered in Boston, Massachusetts, is one of the world’s largest independent asset management firms, overseeing trillions in assets for a diverse client base including pension funds, endowments, and mutual fund investors. Renowned for its active management approach, Wellington offers a broad range of investment strategies across equities, fixed income, multi-asset, and alternative investments, emphasizing deep research and long-term partnerships with clients. The firm gained early fame for launching the Wellington Fund, one of the first balanced mutual funds, and has since maintained a reputation for disciplined, collaborative portfolio management. With a global presence and a focus on customized solutions, Wellington remains a trusted name in institutional and retail investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$1B |
| 2 |
Merck
MRK
|
+$986M |
| 3 |
Abbott
ABT
|
+$969M |
| 4 |
NVIDIA
NVDA
|
+$967M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$814M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$2.46B |
| 2 |
Morgan Stanley
MS
|
+$910M |
| 3 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$909M |
| 4 |
Coca-Cola
KO
|
+$745M |
| 5 |
Arista Networks
ANET
|
+$692M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.51% |
| 2 | Technology | 19.42% |
| 3 | Financials | 12.78% |
| 4 | Industrials | 10.08% |
| 5 | Consumer Discretionary | 9.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1526
Willis Towers Watson
WTW
$31.5B
| $925K | ﹤0.01% |
3,928
-908
| -19% | -$209K |
|
1527
Wave Life Sciences
WVE
$1.18B
| $925K | ﹤0.01% |
254,055
+9,057
| +4% | +$36.6K |
|
1528
Riot Platforms
RIOT
$8.15B
| $923K | ﹤0.01% |
78,130
-38,230
| -33% | -$428K |
|
1529
Voyager Therapeutics
VYGR
$189M
| $923K | ﹤0.01% |
+80,586
| New | +$834K |
|
1530
The Bancorp
TBBK
$3B
| $911K | ﹤0.01% |
27,906
-8,931
| -24% | -$275K |
|
1531
Iovance Biotherapeutics
IOVA
$1.95B
| $910K | ﹤0.01% |
129,200
-25,286
| -16% | -$181K |
|
1532
Trimble
TRMB
$13.9B
| $901K | ﹤0.01% |
17,015
-3,298
| -16% | -$161K |
|
1533
Target
TGT
$67.3B
| $897K | ﹤0.01% |
6,804
-538
| -7% | -$79.8K |
|
1534
Enterprise Products Partners
EPD
$82.5B
| $892K | ﹤0.01% |
33,849
-194,447
| -85% | -$5.08M |
|
|
DCBO
1535
Docebo
DCBO
$523M
| $873K | ﹤0.01% |
22,031
-11,932
| -35% | -$432K |
|
|
RBT
1536
DELISTED
Rubicon Technologies, Inc.
RBT
| $871K | ﹤0.01% |
+294,339
| New | +$1.09M |
|
1537
MarketAxess Holdings
MKTX
$5.71B
| $859K | ﹤0.01% |
3,287
-46,895
| -93% | -$14M |
|
1538
Maravai LifeSciences
MRVI
$948M
| $856K | ﹤0.01% |
68,879
+39,186
| +132% | +$529K |
|
1539
Annaly Capital Management
NLY
$17.1B
| $845K | ﹤0.01% |
42,251
-1,120,151
| -96% | -$21.8M |
|
1540
International Flavors & Fragrances
IFF
$20.7B
| $830K | ﹤0.01% |
10,434
-605
| -5% | -$52.1K |
|
|
CSTR
1541
DELISTED
CapStar Financial Holdings, Inc
CSTR
| $829K | ﹤0.01% |
67,566
-166,667
| -71% | -$2.21M |
|
1542
America Movil
AMX
$74.7B
| $813K | ﹤0.01% |
37,590
+2,696
| +8% | +$58.5K |
|
1543
Benchmark Electronics
BHE
$3.07B
| $812K | ﹤0.01% |
31,454
-1,946
| -6% | -$45K |
|
|
BRKL
1544
DELISTED
Brookline Bancorp
BRKL
| $811K | ﹤0.01% |
92,820
| – | – |
|
1545
Concentrix
CNXC
$1.56B
| $805K | ﹤0.01% |
9,975
-763,349
| -99% | -$71.4M |
|
1546
The Mosaic Company
MOS
$7.22B
| $789K | ﹤0.01% |
22,542
-22,860
| -50% | -$883K |
|
1547
Polaris
PII
$4.2B
| $784K | ﹤0.01% |
6,480
-1,091
| -14% | -$121K |
|
1548
Invitation Homes
INVH
$18.1B
| $772K | ﹤0.01% |
22,439
+12,073
| +116% | +$403K |
|
|
TBNK
1549
DELISTED
Territorial Bancorp Inc.
TBNK
| $767K | ﹤0.01% |
62,491
-1,177
| -2% | -$16.2K |
|
1550
Core Molding Technologies
CMT
$210M
| $760K | ﹤0.01% |
+33,400
| New | +$648K |
|
Similar funds
Wellington Management Group's Q2 2023 Portfolio in Review
As of Q2 2023, Wellington Management Group held 2,099 positions worth $527B, up 4.5% from $505B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Wellington Management Group's Q2 2023 filing shows 119 new, 718 increased, 815 reduced and 304 closed positions. Its largest new stake was Kenvue: 10,602,707 shares worth $280M. The largest sale was Eli Lilly, an estimated $2.46B.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 23% a quarter earlier, followed by Technology and Financials.
- Wellington Management Group's largest Q2 2023 buy was Kenvue: 10,602,707 shares worth $280M.
- Wellington Management Group added most to Gilead Sciences in Q2 2023, an estimated $1B increase.
- Wellington Management Group's biggest Q2 2023 reduction was Eli Lilly, cutting an estimated $2.46B.
- Wellington Management Group fully exited Syneos Health, Inc. Class A Common Stock in Q2 2023, selling an estimated $267M.
- Wellington Management Group's ten largest holdings make up 20% of its $527B portfolio in Q2 2023.
- Wellington Management Group opened 119 new positions and closed 304 in Q2 2023.
- Wellington Management Group's portfolio value rose 4.5% quarter-over-quarter to $527B.
Based on Wellington Management Group's 13F filing for Q2 2023, filed 14 Aug 2023.